Blood vessels recovered with organs and intended for use in organ transplantation. Final rule.
The Food and Drug Administration (FDA) and the Health Resources and Services Administration (HRSA) are amending their regulations to include as part of an organ those blood vessels recovered with the organ that are intended for use in organ transplantation (HRSA regulation); and to exclude such blood vessels from the definition of human cells, tissues, or cellular or tissue-based products (HCT/Ps) (FDA regulation). The purpose of this final rule is to amend the regulations so that blood vessels recovered with organs and intended for use in organ transplantation, and labeled as such, are governed by the regulations pertaining to organs. The regulation of other recovered blood vessels remains unchanged. We (HRSA and FDA) believe that this change will eliminate the burden resulting from an organ procurement organization's efforts to comply with both FDA and HRSA rules with respect to blood vessels (FDA jurisdiction) and organs (HRSA jurisdiction).
D001808:Blood Vessels / Q000637:transplantation*; D006801:Humans; D016377:Organ Transplantation / Q000331:legislation & jurisprudence*; D020858:Tissue and Organ Harvesting / Q000145:classification / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration; D014488:United States Health Resources and Services Administration